| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/13/2007 | WO2007078813A3 2-AMINO-5-PIPERIDINYLIMIDAZOLONE COMPOUNDS AND USE THEREOF FOR β-SECRETASE MODULATION |
| 12/13/2007 | WO2007075964A8 Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery |
| 12/13/2007 | WO2007070865A3 Piperazine compounds as agonists of trpv4 channel receptors |
| 12/13/2007 | WO2007070779A3 A method to treat premature ejaculation in humans |
| 12/13/2007 | WO2007070506A3 Diaza heterocyclic sulfonamide derivatives and their uses |
| 12/13/2007 | WO2007067906A3 Peptide deformylase inhibitors |
| 12/13/2007 | WO2007067619A3 Certain chemical entities, compositions, and methods for modulating trpv1 |
| 12/13/2007 | WO2007065032A3 Compounds and methods for inhibiting viral entry |
| 12/13/2007 | WO2007064926A3 Compositions containing ansamycin |
| 12/13/2007 | WO2007064797A3 Inhibitors of c-met and uses thereof |
| 12/13/2007 | WO2007062112A3 Glyceryl ether compounds and their use |
| 12/13/2007 | WO2007061763A3 Indole orexin receptor antagonists |
| 12/13/2007 | WO2007059108A3 Substituted quinolones and methods of use |
| 12/13/2007 | WO2007056164A3 Aminopyrimidines useful as kinase inhibitors |
| 12/13/2007 | WO2007051133A3 Substituted thiazoles and their use |
| 12/13/2007 | WO2007050599A8 Ginkgolides in the treatment and prevention of ovarian cancer |
| 12/13/2007 | WO2007044796A3 Pyridazinone compounds as calcilytics |
| 12/13/2007 | WO2007038250A3 1,25 - dihydroxy, 20-cyclopropyl, 26-27- deuteroalkyl vitamin d3 compounds and methods of use thereof |
| 12/13/2007 | WO2007038115A3 Ppar-gamma agonists for improvement of cognitive function in apoe4 negative patients |
| 12/13/2007 | WO2007027566A3 Method for removing phosphate and polymer used therefore |
| 12/13/2007 | WO2007011962A3 Treatment of cancer |
| 12/13/2007 | WO2007002191A3 Methods for the preparation of 9-deazapurine derivatives |
| 12/13/2007 | WO2007000193A9 Isoflavone nanoparticles and use thereof |
| 12/13/2007 | WO2006138475A3 Mao-b inhibitors useful for treating obesity |
| 12/13/2007 | WO2006116773A3 Methods, compositions, and compounds for modulation of monoacylglycerol lipase, pain, and stress-related disorders |
| 12/13/2007 | WO2006115548A3 Subunit vaccine against west nile viral infection |
| 12/13/2007 | WO2006113889A3 Compositions and methods for modulating interleukin-10 |
| 12/13/2007 | WO2006113568A8 Controlled delivery dosage form of tramadol and gabapentin |
| 12/13/2007 | WO2006113471A3 N-alkyl-azacycloalkyl nmda/nr2b antagonists |
| 12/13/2007 | WO2006110298A3 8-alkyl/aryl-4-aryl-2-n- (alkylamino)-n'-substituted-n'-cyanoguanidino-8h-pyrido[2,3-d]pyrimidin-7-one compounds and use thereof |
| 12/13/2007 | WO2006102533A3 Pharmaceutically active lipid-based formulation of nucleoside-lipid conjugates |
| 12/13/2007 | WO2006097358A3 Analgesic combination of sodium channel blockers with opioid antagonists |
| 12/13/2007 | WO2006096458A3 Treatment of hyperproliferative diseases with anthraquinones |
| 12/13/2007 | WO2006089942A8 Protease inhibitor precursor synthesis |
| 12/13/2007 | WO2006081396A3 Compositions and methods for delivery of agents into cells |
| 12/13/2007 | WO2006079720A8 Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents |
| 12/13/2007 | WO2006078575A3 Fluorinated aminoalkyl-4-oxo-3,4-dihydropyrido[3,4- d] pyrimidines as inhibitors of mitotic kinesins |
| 12/13/2007 | WO2006074281A3 Inhibitors of checkpoint kinases |
| 12/13/2007 | WO2006065793A3 TREATMENT OF INTERSTITIAL CYSTITIS USING (6aR,10aR)-Δ8-TETRAHYDROCANNABINOL-11-OIC ACIDS |
| 12/13/2007 | WO2006044663A3 THIO-siRNA APTAMERS |
| 12/13/2007 | WO2005115417A3 Polycationic antimicrobial therapeutic |
| 12/13/2007 | WO2005048916A3 Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders |
| 12/13/2007 | WO2005034852A3 Protein biomaterials and biocoacervates and methods of making and using thereof |
| 12/13/2007 | WO2004069195A8 Methods and compositions for treating inflammatory disorders of the airways |
| 12/13/2007 | WO2003037306A3 Inhalation of vapour of therapeutical substances, like e.g. cannabis extract |
| 12/13/2007 | US20070287988 Method and composition for treating osteonecrosis and/or avascular necrosis |
| 12/13/2007 | US20070287931 Methods and systems for administering an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders |
| 12/13/2007 | US20070287755 Orally administered compound for preventing neonatal hemorrhages, in a tardy form, caused by a K-vitamin dificiency |
| 12/13/2007 | US20070287754 Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor |
| 12/13/2007 | US20070287753 Intranasal Administration of Ketamine to Treat Depression |
| 12/13/2007 | US20070287752 Ophthalmic Compositions Comprising A Branched, Glycerol Compound |
| 12/13/2007 | US20070287751 Therapy for obesity; using a secondary amino compound |
| 12/13/2007 | US20070287750 Polycationic sulfonamides and use thereof |
| 12/13/2007 | US20070287749 Bromfenac ophthalmic formulations and methods of use |
| 12/13/2007 | US20070287748 Intermediate in the synthesis of (S)-Pregabalin; precipitation |
| 12/13/2007 | US20070287747 Process for Preparing Metal Salts of Unsaturated, Short-Chain Carboxylic Acids and Use Thereof |
| 12/13/2007 | US20070287746 Use of Anti-Oxidant Compounds for Muscle Recovery |
| 12/13/2007 | US20070287745 Laulimalide Analogs and Uses Thereof |
| 12/13/2007 | US20070287744 N-[(4,5-diphenyl-2-thienyl)methyl]sulfonamide derivatives, preparation thereof and their therapeutic application |
| 12/13/2007 | US20070287743 Adamantyl Pyrrolidin-2-One Derivatives as 11-Beta Hydroxtsteroid Dehydrogenase Inhibitors |
| 12/13/2007 | US20070287742 Subsitituted Gamma Lactams As Therapeutic Agents |
| 12/13/2007 | US20070287741 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals |
| 12/13/2007 | US20070287740 Compositions and methods of treating middle-of-the night insomnia |
| 12/13/2007 | US20070287739 Aryl-4-ethynyl-isoxazole derivatives |
| 12/13/2007 | US20070287738 Substituted Cyanopyridines as protein kinase inhibitors |
| 12/13/2007 | US20070287737 Novel heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors |
| 12/13/2007 | US20070287736 Diphenyl Substituted Alkanes as Flap Inhibitors |
| 12/13/2007 | US20070287735 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 12/13/2007 | US20070287734 Preparation and utility of substituted pyrazole compounds with cannabinoid receptor activity |
| 12/13/2007 | US20070287733 Method of Treating Skin Diseases |
| 12/13/2007 | US20070287732 highly potent; side effect reduction; for the treatment of diseases of the respiratory, urinary and gastrointestinal systems; 3-(2-Methoxy-5-methylphenyl)-3-phenylpropionic acid-(3-benzyl-3-azabicyclo[3.1.0]hex-6-yl-carbamoyl)methyl ester; condensation; deprotection |
| 12/13/2007 | US20070287731 1-Benzyl-3-[3-(3,5-dimethyl-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-urea; nuclear receptor-based inducible gene expression system |
| 12/13/2007 | US20070287730 useful for the treatment of HIV and AIDS |
| 12/13/2007 | US20070287729 Aqueous Ophthalmic Suspension of Crystalline Rebamipide |
| 12/13/2007 | US20070287728 Novel Naphthyl Substituted Azabicyclo Derivatives and Their Use as Monomine Neurotransmitter Re-Uptake Inhibitors |
| 12/13/2007 | US20070287727 Anti-Nicotine Treatment |
| 12/13/2007 | US20070287726 5-Substituted 1H-Pyrrolo [3,2-B] Pyridines |
| 12/13/2007 | US20070287725 Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Compounds And Method |
| 12/13/2007 | US20070287724 Substituted Imidazoquinolines, Imidazopyridines, and Imidazonaphthyridines |
| 12/13/2007 | US20070287723 2-alkyl/aryl sulphonyl-1,2,3,4-tetrahydro-9h-pyrido (3,4-b) indole-3-carboxylic acid esters/amides useful as antithrombotic agents |
| 12/13/2007 | US20070287722 Drop Preparations Comprising Dimetindene |
| 12/13/2007 | US20070287721 Pyrazolopyridinyl pyridine |
| 12/13/2007 | US20070287719 Salts, Prodrugs and Formulations of 1-[5-(4-Amino-7-Isopropyl-7H-Pyrrolo[2,3-D]Pyrimidine-5-Carbonyl)-2-Methoxy-Phenyl]-3-(2,4-Dichloro-Phenyl)-Urea |
| 12/13/2007 | US20070287718 Methods for the Treatment of Multiple Myeloma Using Roscovitine |
| 12/13/2007 | US20070287717 Thienopyrimidines useful as modulators of ion channels |
| 12/13/2007 | US20070287716 Pyrimidine and Quinoline Potentiators of Metabotropic Glutamate Receptors |
| 12/13/2007 | US20070287715 e.g.5-(4-tert-Butylphenyl-1-(4-(2-carboxypropan-2-yloxy)phenyl)indole-2-carboxylic acid ; inhibition of the activity of microsomal prostaglandin E synthase-1, 5-lipoxygenase-activating protein (FLAP); respiratory system disorders |
| 12/13/2007 | US20070287714 Warming and Nonirritating Lubricant Compositions and Method of Comparing Irritation |
| 12/13/2007 | US20070287713 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 12/13/2007 | US20070287712 antiviral agents for the treatment of HIV and AIDS; indole and azaindole piperazine enamine derivatives; 2-((4-(2-(4-fluoro-7-(1H-1,2,3-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoacetyl)piperazin-1-yl)(phenyl)methylene)malononitrile |
| 12/13/2007 | US20070287711 Fused ring heterocycle kinase modulators |
| 12/13/2007 | US20070287710 Piperidinediyl-containing sulfonamide; NPY Y5 receptor antagonist activity; antiobesity agent or anorectic agent |
| 12/13/2007 | US20070287709 Novel arylamino N-heteraryls as MEK inhibitors |
| 12/13/2007 | US20070287708 Substituted 3-cyanopyridines as protein kinase inhibitors |
| 12/13/2007 | US20070287707 Phosphodiesterase 10 inhibitors |
| 12/13/2007 | US20070287706 Certain substituted quinolones, compositions, and uses thereof |
| 12/13/2007 | US20070287705 Crf Receptor Antagonists and Methods Relating Thereto |
| 12/13/2007 | US20070287704 7-amino-6-chloro-2-piperazin-1-yl-4-pyrrolidin-1-yl-pteridine; central nervous system, respiratory, gastrointestinal or inflammatory diseases; joints, skin or eyes diseases; cancer; phosphodiesterase 4 inhibitors |
| 12/13/2007 | US20070287703 Fused Pyrimidones Useful in the Treatment and the Prevention of Cancer |
| 12/13/2007 | US20070287702 Thioridazine And Derivatives Thereof For Reversing Anti-Microbial Drug-Resistance |